Best Practices for Timely Deviation Documentation in Pharma Stability Testing
In the pharmaceutical industry, timely and accurate deviation documentation is critical to maintaining GxP compliance, preserving data integrity, and demonstrating control over the stability program. Delays in logging or investigating deviations can trigger audit observations, misaligned data sets, and loss of product integrity. This article outlines proven best practices to ensure that deviations during stability…
Read More “Best Practices for Timely Deviation Documentation in Pharma Stability Testing” »
